Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024
15 Fevereiro 2024 - 6:05PM
Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision
medicine company transforming the drug discovery process by
combining leading-edge computational and experimental technologies,
will report fourth quarter and full year 2023 financial results and
corporate highlights after the U.S. financial markets close on
Thursday, February 22, 2024.
About Relay Therapeutics
Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision
medicine company transforming the drug discovery process by
combining leading-edge computational and experimental technologies
with the goal of bringing life-changing therapies to patients. As
the first of a new breed of biotech created at the intersection of
complementary techniques and technologies, Relay Therapeutics aims
to push the boundaries of what’s possible in drug discovery. Its
Dynamo™ platform integrates an array of leading-edge computational
and experimental approaches designed to drug protein targets that
have previously been intractable or inadequately addressed. Relay
Therapeutics’ initial focus is on enhancing small molecule
therapeutic discovery in targeted oncology and genetic disease
indications. For more information, please visit www.relaytx.com or
follow us on Twitter.
Contact:Megan Goulart617-545-5526
mgoulart@relaytx.com
Media:Dan
Budwick1AB973-271-6085dan@1abmedia.com
Relay Therapeutics (NASDAQ:RLAY)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Relay Therapeutics (NASDAQ:RLAY)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024